We demonstrated that pancreatic cancers with an immune phenotype of low CD8+ T cell infiltration and high PD-L1 expression were associated with worse clinical outcomes compared to cancers with high CD8+ T cell infiltration and low PD- L1 expression. This evidence concerns the gene CD8A and familial pancreatic carcinoma.